The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O 6 -alkylguanine-DNA-alkyltransferase of human tumour xenografts

By D'Incalci M.   Bonfanti M.   Pifferi A.   Mascellani E.   Tagliabue G.   Berger D.   Fiebig H.H.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1749-1755

Elsevier

Access to resources Recommend Favorite

Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity

By Fourie Jeanne   Guziec Frank   Guziec Lynn   Monterrosa Cielo   Fiterman Derek   Begleiter Asher  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 191-203

Springer Publishing Company

Access to resources Recommend Favorite

Prophage Inductive Efficiency of Alkylating Agents and Radiations

By Hussain Saeed   Ehrenberg Lars  

International Journal of Radiation Biology, Vol. 27, Iss. 4, 1975-04 ,pp. : 355-362

Informa Healthcare

Access to resources Recommend Favorite

Activity and toxicity profiles of the combinations bendamustine–lenalidomide–dexamethasone and bendamustine–bortezomib–dexamethasone for advanced stage multiple myeloma

By Mele Giuseppe   Spina Alessandro   Guaragna Gianluca   Giannotta Angela   Melpignano Angela   Quarta Gianni  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1191-1193

Informa Healthcare

Access to resources Recommend Favorite

Design of Novel Antitumor DNA Alkylating Agents: The Benzacronycine Series

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-03 ,pp. : 83-92

Bentham Science Publishers

Access to resources Recommend Favorite